Clinical Manifestations of Recurrent Parotid Pleomorphic Adenoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA. Methods. The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity. Results. Mean age of initial operation in RPA without MT (RPA-MT) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA+MT) group was significantly greater than that of RPA-MT group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA-MT group tumor recurrence occurred in 21.4% of patients despite a clear resection margin. Conclusion. The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.
Abstract
Objectives. This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA. Methods. The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity. Results. Mean age of initial operation in RPA without MT (RPA-MT) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA+MT) group was significantly greater than that of RPA-MT group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA-MT group tumor recurrence occurred in 21.4% of patients despite a clear resection margin. Conclusion. The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.
참고문헌 (25)
- Hanna EY, "Benign neoplasms of the salivery glands. in: Cummings Otolaryngology:Head & Neck Surgery", pp.1348~1377 (2005), Mosby
- Suh MW, "Immunohistochemical characteristics of primary and recurrent pleomorphic adenoma", Korean J Head Neck Oncol., 21(2), pp.146~150 (2005)
- Junquera L, "Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study", Head Neck, 21(7), pp.652~656 (1999)
- Bankamp DG, "Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands", Laryngorhinootologie, 78(2), pp.77~80 (1999)
- Leverstein H, "The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland: analysis and results in 40 patients", Eur Arch Otorhinolaryngol, 254(7), pp.313~317 (1997)
- Jackson SR, "Recurrent pleomorphic adenoma", J Laryngol Otol, 107(6), pp.546~549 (1993)
- Hancock BD, "Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases", Ann Royal Coll Surg Engl, 81(5), pp.299~301 (1999)
- Bradley PJ, "Recurrent salivary gland pleomorphic adenoma: etiology, management, and results", Curr Opin Otolaryngol Head Neck Surg, 9(2), pp.100~108 (2001)
- Seifert G, "A pathological classification of pleomorphic adenoma of the salivary glands (author’s transl)", HNO, 24(12), pp.415~426 (1976)
- Frazell EL, "Clinical aspects of tumors of the major salivary glands", Cancer, 7(4), pp.637~659 (1954)
- Ghosh S, "Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management: a 12.5-year mean follow-up study of histologically marginal excisions", Clin Otolaryngol Allied Sci, 28(3), pp.262~266 (2003)
- Buchman C, "Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence", Laryngoscope, 104(10), pp.1231~1234 (1994)
- Henriksson G, "Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia", Cancer, 82(4), pp.617~620 (1998)
- Natvig K, "Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study", Head Neck, 16(3), pp.213~217 (1994)
- Carew JF, "Treatment of recurrent pleomorphic adenomas of the parotid gland", Otolaryngol Head Neck Surg, 121(5), pp.539~542 (1999)
- Glas AS, "Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients", Head Neck, 23(4), pp.311~316 (2001)
- Hoorweg JJ, "Metastasizing pleomorphic adenoma: a report of three cases", Eur J Surg Oncol, 24(5), pp.452~455 (1998)
- Klijanienko J, "Clinically aggressive metastasizing pleomorphic adenoma: report of two cases", Head Neck, 19(7), pp.629~633 (1997)
- Sunardhi-Widyaputra S, "Immunohistochemical pattern of Bcl-2- and PTHrP-positive cells in primary, in recurrent and in carcinoma in pleomorphic adenomas", Pathol Res Pract, 191(12), pp.1186~1191 (1995)
- McGregor AD, "Recurrent pleomorphic salivary adenoma: the relevance of age at first presentation", Br J Plast Surg, 41(2), pp.177~181 (1988)
- Fee WE Jr, "Recurrent mixed tumors of the parotid gland: results of surgical therapy", Laryngoscope, 88(2), pp.265~273 (1978)
- Laskawi R, "Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up", Br J Oral Maxillofac Surg, 36(1), pp.48~51 (1998)
- Phillips PP, "Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature", Ann Otol Rhinol Laryngol, 104(2), pp.100~104 (1995)
- Glas AS, "Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland", Cancer, 94(8), pp.2211~2216 (2002)
- Naeim F, "Mixed tumors of the salivary glands: growth pattern and recurrence", Arch Pathol Lab Med, 100(5), pp.271~275 (1976)